PR Title: |
'Next-generation therapeutic antibody revenues to reach $2.3bn in 2015' reports Visiongain |
PR Summary: |
Visiongain predicts that the antibody therapeutics sector will be revitalised by the approval of next-generation products this decade. Overall next-generation therapeutic antibody revenues will reach $2.3bn in 2015. |